nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—hypertension—type 2 diabetes mellitus	0.444	1	CtDrD
Prazosin—ADRA2A—type 2 diabetes mellitus	0.14	1	CbGaD
Prazosin—ORM1—Nateglinide—type 2 diabetes mellitus	0.028	0.107	CbGbCtD
Prazosin—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0275	0.105	CbGbCtD
Prazosin—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0264	0.101	CbGbCtD
Prazosin—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0227	0.0868	CbGbCtD
Prazosin—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0192	0.0733	CbGbCtD
Prazosin—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0165	0.0631	CbGbCtD
Prazosin—SLC22A3—Metformin—type 2 diabetes mellitus	0.016	0.061	CbGbCtD
Prazosin—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0158	0.0603	CbGbCtD
Prazosin—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0152	0.0579	CbGbCtD
Prazosin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0126	0.0481	CbGbCtD
Prazosin—ABCG2—Glyburide—type 2 diabetes mellitus	0.0115	0.044	CbGbCtD
Prazosin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0112	0.0429	CbGbCtD
Prazosin—SLC22A2—Metformin—type 2 diabetes mellitus	0.00947	0.0361	CbGbCtD
Prazosin—SLC22A1—Metformin—type 2 diabetes mellitus	0.00822	0.0314	CbGbCtD
Prazosin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00812	0.031	CbGbCtD
Prazosin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00558	0.0213	CbGbCtD
Prazosin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00416	0.0159	CbGbCtD
Prazosin—ABCB1—Losartan—type 2 diabetes mellitus	0.0038	0.0145	CbGbCtD
Prazosin—MT3—nerve—type 2 diabetes mellitus	0.00218	0.209	CbGeAlD
Prazosin—HTR1D—artery—type 2 diabetes mellitus	0.000649	0.0623	CbGeAlD
Prazosin—KCNH6—nephron tubule—type 2 diabetes mellitus	0.000606	0.0582	CbGeAlD
Prazosin—KCNH6—kidney—type 2 diabetes mellitus	0.000533	0.0512	CbGeAlD
Prazosin—Doxazosin—ADRA2A—type 2 diabetes mellitus	0.000486	0.586	CrCbGaD
Prazosin—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000482	0.0463	CbGeAlD
Prazosin—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000359	0.0344	CbGeAlD
Prazosin—Alfuzosin—CYP3A4—type 2 diabetes mellitus	0.000344	0.414	CrCbGaD
Prazosin—SLC22A2—kidney—type 2 diabetes mellitus	0.000315	0.0303	CbGeAlD
Prazosin—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000307	0.0295	CbGeAlD
Prazosin—ADRA1B—kidney—type 2 diabetes mellitus	0.000302	0.029	CbGeAlD
Prazosin—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000231	0.0222	CbGeAlD
Prazosin—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000225	0.0217	CbGeAlD
Prazosin—SLC22A1—kidney—type 2 diabetes mellitus	0.000223	0.0214	CbGeAlD
Prazosin—HTR1D—kidney—type 2 diabetes mellitus	0.000221	0.0212	CbGeAlD
Prazosin—SLC22A3—kidney—type 2 diabetes mellitus	0.000213	0.0204	CbGeAlD
Prazosin—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000201	0.0193	CbGeAlD
Prazosin—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000192	0.0184	CbGeAlD
Prazosin—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000188	0.018	CbGeAlD
Prazosin—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000182	0.0175	CbGeAlD
Prazosin—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000173	0.0166	CbGeAlD
Prazosin—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000167	0.0161	CbGeAlD
Prazosin—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000166	0.0159	CbGeAlD
Prazosin—ORM1—liver—type 2 diabetes mellitus	0.000154	0.0148	CbGeAlD
Prazosin—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000153	0.0147	CbGeAlD
Prazosin—SLC22A1—liver—type 2 diabetes mellitus	0.000141	0.0135	CbGeAlD
Prazosin—CYP1A1—kidney—type 2 diabetes mellitus	0.000138	0.0133	CbGeAlD
Prazosin—SLC22A3—liver—type 2 diabetes mellitus	0.000134	0.0129	CbGeAlD
Prazosin—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000131	0.0126	CbGeAlD
Prazosin—ADRA2A—pancreas—type 2 diabetes mellitus	0.000128	0.0123	CbGeAlD
Prazosin—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000126	0.0121	CbGeAlD
Prazosin—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000125	0.012	CbGeAlD
Prazosin—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00012	0.00148	CcSEcCtD
Prazosin—Vision blurred—Metformin—type 2 diabetes mellitus	0.00012	0.00148	CcSEcCtD
Prazosin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00012	0.00148	CcSEcCtD
Prazosin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00147	CcSEcCtD
Prazosin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000119	0.00146	CcSEcCtD
Prazosin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000119	0.00146	CcSEcCtD
Prazosin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000119	0.00146	CcSEcCtD
Prazosin—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000118	0.00145	CcSEcCtD
Prazosin—Tension—Irbesartan—type 2 diabetes mellitus	0.000118	0.00145	CcSEcCtD
Prazosin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000118	0.00145	CcSEcCtD
Prazosin—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000117	0.00144	CcSEcCtD
Prazosin—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000117	0.00144	CcSEcCtD
Prazosin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000116	0.00143	CcSEcCtD
Prazosin—Discomfort—Orlistat—type 2 diabetes mellitus	0.000116	0.00143	CcSEcCtD
Prazosin—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000116	0.0112	CbGeAlD
Prazosin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000115	0.00141	CcSEcCtD
Prazosin—Malaise—Metformin—type 2 diabetes mellitus	0.000115	0.00141	CcSEcCtD
Prazosin—Alopecia—Losartan—type 2 diabetes mellitus	0.000115	0.00141	CcSEcCtD
Prazosin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000115	0.00141	CcSEcCtD
Prazosin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00141	CcSEcCtD
Prazosin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000114	0.00141	CcSEcCtD
Prazosin—Syncope—Metformin—type 2 diabetes mellitus	0.000114	0.0014	CcSEcCtD
Prazosin—Oedema—Valsartan—type 2 diabetes mellitus	0.000114	0.0014	CcSEcCtD
Prazosin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000114	0.0014	CcSEcCtD
Prazosin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000114	0.0014	CcSEcCtD
Prazosin—Rash—Glipizide—type 2 diabetes mellitus	0.000113	0.00139	CcSEcCtD
Prazosin—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000113	0.00139	CcSEcCtD
Prazosin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000113	0.00139	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000113	0.00139	CcSEcCtD
Prazosin—Oedema—Orlistat—type 2 diabetes mellitus	0.000113	0.00139	CcSEcCtD
Prazosin—Headache—Glipizide—type 2 diabetes mellitus	0.000113	0.00138	CcSEcCtD
Prazosin—Palpitations—Metformin—type 2 diabetes mellitus	0.000113	0.00138	CcSEcCtD
Prazosin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000112	0.00138	CcSEcCtD
Prazosin—Shock—Valsartan—type 2 diabetes mellitus	0.000112	0.00138	CcSEcCtD
Prazosin—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000112	0.00138	CcSEcCtD
Prazosin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000112	0.00137	CcSEcCtD
Prazosin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000112	0.00137	CcSEcCtD
Prazosin—Tension—Losartan—type 2 diabetes mellitus	0.000111	0.00136	CcSEcCtD
Prazosin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000111	0.00136	CcSEcCtD
Prazosin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000111	0.00136	CcSEcCtD
Prazosin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000111	0.00136	CcSEcCtD
Prazosin—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00011	0.00136	CcSEcCtD
Prazosin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00011	0.00135	CcSEcCtD
Prazosin—Nervousness—Losartan—type 2 diabetes mellitus	0.00011	0.00135	CcSEcCtD
Prazosin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000109	0.00134	CcSEcCtD
Prazosin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00133	CcSEcCtD
Prazosin—Malaise—Irbesartan—type 2 diabetes mellitus	0.000108	0.00133	CcSEcCtD
Prazosin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000108	0.00133	CcSEcCtD
Prazosin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000108	0.00133	CcSEcCtD
Prazosin—Syncope—Irbesartan—type 2 diabetes mellitus	0.000108	0.00133	CcSEcCtD
Prazosin—Discomfort—Metformin—type 2 diabetes mellitus	0.000107	0.00132	CcSEcCtD
Prazosin—ADRA1A—liver—type 2 diabetes mellitus	0.000107	0.0103	CbGeAlD
Prazosin—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000107	0.00132	CcSEcCtD
Prazosin—Nausea—Glipizide—type 2 diabetes mellitus	0.000107	0.00131	CcSEcCtD
Prazosin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000107	0.00131	CcSEcCtD
Prazosin—Vision blurred—Losartan—type 2 diabetes mellitus	0.000107	0.00131	CcSEcCtD
Prazosin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00131	CcSEcCtD
Prazosin—Pain—Gliclazide—type 2 diabetes mellitus	0.000106	0.00131	CcSEcCtD
Prazosin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000106	0.00131	CcSEcCtD
Prazosin—Rash—Glimepiride—type 2 diabetes mellitus	0.000106	0.0013	CcSEcCtD
Prazosin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000106	0.0013	CcSEcCtD
Prazosin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000106	0.0013	CcSEcCtD
Prazosin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000105	0.0013	CcSEcCtD
Prazosin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000105	0.0013	CcSEcCtD
Prazosin—Headache—Glimepiride—type 2 diabetes mellitus	0.000105	0.00129	CcSEcCtD
Prazosin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.00129	CcSEcCtD
Prazosin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.00129	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000104	0.00128	CcSEcCtD
Prazosin—Oedema—Metformin—type 2 diabetes mellitus	0.000104	0.00128	CcSEcCtD
Prazosin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.00128	CcSEcCtD
Prazosin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00127	CcSEcCtD
Prazosin—Flushing—Ramipril—type 2 diabetes mellitus	0.000103	0.00127	CcSEcCtD
Prazosin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000103	0.00127	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.00126	CcSEcCtD
Prazosin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000102	0.00126	CcSEcCtD
Prazosin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000102	0.00126	CcSEcCtD
Prazosin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000102	0.00126	CcSEcCtD
Prazosin—Shock—Metformin—type 2 diabetes mellitus	0.000102	0.00126	CcSEcCtD
Prazosin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000102	0.00125	CcSEcCtD
Prazosin—Malaise—Losartan—type 2 diabetes mellitus	0.000102	0.00125	CcSEcCtD
Prazosin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000102	0.00125	CcSEcCtD
Prazosin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.00125	CcSEcCtD
Prazosin—Vertigo—Losartan—type 2 diabetes mellitus	0.000102	0.00125	CcSEcCtD
Prazosin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000101	0.00975	CbGeAlD
Prazosin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000101	0.00125	CcSEcCtD
Prazosin—Syncope—Losartan—type 2 diabetes mellitus	0.000101	0.00125	CcSEcCtD
Prazosin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000101	0.00125	CcSEcCtD
Prazosin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000101	0.00124	CcSEcCtD
Prazosin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.0001	0.00124	CcSEcCtD
Prazosin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0001	0.00123	CcSEcCtD
Prazosin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.0001	0.00123	CcSEcCtD
Prazosin—Palpitations—Losartan—type 2 diabetes mellitus	0.0001	0.00123	CcSEcCtD
Prazosin—Nausea—Glimepiride—type 2 diabetes mellitus	9.97e-05	0.00123	CcSEcCtD
Prazosin—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.94e-05	0.00122	CcSEcCtD
Prazosin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.93e-05	0.00122	CcSEcCtD
Prazosin—Asthenia—Glyburide—type 2 diabetes mellitus	9.93e-05	0.00122	CcSEcCtD
Prazosin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.00121	CcSEcCtD
Prazosin—Alopecia—Ramipril—type 2 diabetes mellitus	9.85e-05	0.00121	CcSEcCtD
Prazosin—Fatigue—Valsartan—type 2 diabetes mellitus	9.84e-05	0.00121	CcSEcCtD
Prazosin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.82e-05	0.00121	CcSEcCtD
Prazosin—Oedema—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00121	CcSEcCtD
Prazosin—Pruritus—Glyburide—type 2 diabetes mellitus	9.79e-05	0.0012	CcSEcCtD
Prazosin—Constipation—Valsartan—type 2 diabetes mellitus	9.76e-05	0.0012	CcSEcCtD
Prazosin—Fatigue—Orlistat—type 2 diabetes mellitus	9.72e-05	0.0012	CcSEcCtD
Prazosin—Shock—Irbesartan—type 2 diabetes mellitus	9.65e-05	0.00119	CcSEcCtD
Prazosin—Pain—Orlistat—type 2 diabetes mellitus	9.65e-05	0.00119	CcSEcCtD
Prazosin—Arthralgia—Losartan—type 2 diabetes mellitus	9.63e-05	0.00118	CcSEcCtD
Prazosin—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.62e-05	0.00118	CcSEcCtD
Prazosin—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.00118	CcSEcCtD
Prazosin—Rash—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.00117	CcSEcCtD
Prazosin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.53e-05	0.00117	CcSEcCtD
Prazosin—Tension—Ramipril—type 2 diabetes mellitus	9.52e-05	0.00117	CcSEcCtD
Prazosin—Discomfort—Losartan—type 2 diabetes mellitus	9.51e-05	0.00117	CcSEcCtD
Prazosin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.48e-05	0.00117	CcSEcCtD
Prazosin—Headache—Bromocriptine—type 2 diabetes mellitus	9.48e-05	0.00117	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.47e-05	0.00116	CcSEcCtD
Prazosin—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.47e-05	0.00116	CcSEcCtD
Prazosin—Nervousness—Ramipril—type 2 diabetes mellitus	9.42e-05	0.00116	CcSEcCtD
Prazosin—Dry mouth—Losartan—type 2 diabetes mellitus	9.42e-05	0.00116	CcSEcCtD
Prazosin—Paraesthesia—Metformin—type 2 diabetes mellitus	9.33e-05	0.00115	CcSEcCtD
Prazosin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.29e-05	0.00114	CcSEcCtD
Prazosin—Dyspnoea—Metformin—type 2 diabetes mellitus	9.27e-05	0.00114	CcSEcCtD
Prazosin—Somnolence—Metformin—type 2 diabetes mellitus	9.24e-05	0.00114	CcSEcCtD
Prazosin—Oedema—Losartan—type 2 diabetes mellitus	9.23e-05	0.00113	CcSEcCtD
Prazosin—ABCG2—liver—type 2 diabetes mellitus	9.2e-05	0.00884	CbGeAlD
Prazosin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.15e-05	0.00113	CcSEcCtD
Prazosin—Shock—Losartan—type 2 diabetes mellitus	9.08e-05	0.00112	CcSEcCtD
Prazosin—Urticaria—Valsartan—type 2 diabetes mellitus	9.07e-05	0.00111	CcSEcCtD
Prazosin—Tachycardia—Losartan—type 2 diabetes mellitus	9.01e-05	0.00111	CcSEcCtD
Prazosin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9e-05	0.00111	CcSEcCtD
Prazosin—Nausea—Bromocriptine—type 2 diabetes mellitus	8.99e-05	0.00111	CcSEcCtD
Prazosin—Fatigue—Metformin—type 2 diabetes mellitus	8.96e-05	0.0011	CcSEcCtD
Prazosin—Urticaria—Orlistat—type 2 diabetes mellitus	8.96e-05	0.0011	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.0011	CcSEcCtD
Prazosin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.92e-05	0.0011	CcSEcCtD
Prazosin—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.92e-05	0.0011	CcSEcCtD
Prazosin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.91e-05	0.0011	CcSEcCtD
Prazosin—Constipation—Metformin—type 2 diabetes mellitus	8.89e-05	0.00109	CcSEcCtD
Prazosin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.00108	CcSEcCtD
Prazosin—Vomiting—Glyburide—type 2 diabetes mellitus	8.8e-05	0.00108	CcSEcCtD
Prazosin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.79e-05	0.00108	CcSEcCtD
Prazosin—Malaise—Ramipril—type 2 diabetes mellitus	8.75e-05	0.00108	CcSEcCtD
Prazosin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.00108	CcSEcCtD
Prazosin—CYP1A1—liver—type 2 diabetes mellitus	8.74e-05	0.00839	CbGeAlD
Prazosin—Rash—Glyburide—type 2 diabetes mellitus	8.72e-05	0.00107	CcSEcCtD
Prazosin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.72e-05	0.00107	CcSEcCtD
Prazosin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.72e-05	0.00107	CcSEcCtD
Prazosin—Vertigo—Ramipril—type 2 diabetes mellitus	8.71e-05	0.00107	CcSEcCtD
Prazosin—Syncope—Ramipril—type 2 diabetes mellitus	8.7e-05	0.00107	CcSEcCtD
Prazosin—ABCB1—retina—type 2 diabetes mellitus	8.68e-05	0.00833	CbGeAlD
Prazosin—Headache—Glyburide—type 2 diabetes mellitus	8.67e-05	0.00107	CcSEcCtD
Prazosin—Palpitations—Ramipril—type 2 diabetes mellitus	8.57e-05	0.00105	CcSEcCtD
Prazosin—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.57e-05	0.00105	CcSEcCtD
Prazosin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.52e-05	0.00105	CcSEcCtD
Prazosin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.5e-05	0.00105	CcSEcCtD
Prazosin—Fatigue—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.00104	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.41e-05	0.00103	CcSEcCtD
Prazosin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.41e-05	0.00103	CcSEcCtD
Prazosin—Pain—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.00103	CcSEcCtD
Prazosin—Constipation—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.00103	CcSEcCtD
Prazosin—Insomnia—Losartan—type 2 diabetes mellitus	8.35e-05	0.00103	CcSEcCtD
Prazosin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.31e-05	0.00102	CcSEcCtD
Prazosin—Paraesthesia—Losartan—type 2 diabetes mellitus	8.29e-05	0.00102	CcSEcCtD
Prazosin—Urticaria—Metformin—type 2 diabetes mellitus	8.26e-05	0.00102	CcSEcCtD
Prazosin—Arthralgia—Ramipril—type 2 diabetes mellitus	8.26e-05	0.00102	CcSEcCtD
Prazosin—Dyspnoea—Losartan—type 2 diabetes mellitus	8.23e-05	0.00101	CcSEcCtD
Prazosin—Nausea—Glyburide—type 2 diabetes mellitus	8.22e-05	0.00101	CcSEcCtD
Prazosin—Dizziness—Gliclazide—type 2 diabetes mellitus	8.22e-05	0.00101	CcSEcCtD
Prazosin—Somnolence—Losartan—type 2 diabetes mellitus	8.21e-05	0.00101	CcSEcCtD
Prazosin—Asthenia—Valsartan—type 2 diabetes mellitus	8.19e-05	0.00101	CcSEcCtD
Prazosin—ABCB1—nephron tubule—type 2 diabetes mellitus	8.17e-05	0.00785	CbGeAlD
Prazosin—Discomfort—Ramipril—type 2 diabetes mellitus	8.16e-05	0.001	CcSEcCtD
Prazosin—Asthenia—Orlistat—type 2 diabetes mellitus	8.09e-05	0.000995	CcSEcCtD
Prazosin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.08e-05	0.000994	CcSEcCtD
Prazosin—Pruritus—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000993	CcSEcCtD
Prazosin—Dry mouth—Ramipril—type 2 diabetes mellitus	8.08e-05	0.000993	CcSEcCtD
Prazosin—Pruritus—Orlistat—type 2 diabetes mellitus	7.98e-05	0.000981	CcSEcCtD
Prazosin—Fatigue—Losartan—type 2 diabetes mellitus	7.96e-05	0.000978	CcSEcCtD
Prazosin—Oedema—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000973	CcSEcCtD
Prazosin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.9e-05	0.000971	CcSEcCtD
Prazosin—Pain—Losartan—type 2 diabetes mellitus	7.89e-05	0.00097	CcSEcCtD
Prazosin—Constipation—Losartan—type 2 diabetes mellitus	7.89e-05	0.00097	CcSEcCtD
Prazosin—Rash—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000963	CcSEcCtD
Prazosin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000962	CcSEcCtD
Prazosin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.81e-05	0.00096	CcSEcCtD
Prazosin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000958	CcSEcCtD
Prazosin—Shock—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000957	CcSEcCtD
Prazosin—Headache—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.000957	CcSEcCtD
Prazosin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000953	CcSEcCtD
Prazosin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.73e-05	0.00095	CcSEcCtD
Prazosin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000949	CcSEcCtD
Prazosin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.65e-05	0.000941	CcSEcCtD
Prazosin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.61e-05	0.000935	CcSEcCtD
Prazosin—Dizziness—Valsartan—type 2 diabetes mellitus	7.55e-05	0.000928	CcSEcCtD
Prazosin—Dizziness—Orlistat—type 2 diabetes mellitus	7.46e-05	0.000917	CcSEcCtD
Prazosin—Asthenia—Metformin—type 2 diabetes mellitus	7.46e-05	0.000917	CcSEcCtD
Prazosin—Nausea—Gliclazide—type 2 diabetes mellitus	7.38e-05	0.000907	CcSEcCtD
Prazosin—Pruritus—Metformin—type 2 diabetes mellitus	7.35e-05	0.000904	CcSEcCtD
Prazosin—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.34e-05	0.00705	CbGeAlD
Prazosin—Urticaria—Losartan—type 2 diabetes mellitus	7.33e-05	0.000902	CcSEcCtD
Prazosin—Body temperature increased—Losartan—type 2 diabetes mellitus	7.3e-05	0.000897	CcSEcCtD
Prazosin—Vomiting—Valsartan—type 2 diabetes mellitus	7.26e-05	0.000892	CcSEcCtD
Prazosin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000888	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000887	CcSEcCtD
Prazosin—Rash—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000885	CcSEcCtD
Prazosin—Dermatitis—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000884	CcSEcCtD
Prazosin—ABCB1—kidney—type 2 diabetes mellitus	7.18e-05	0.0069	CbGeAlD
Prazosin—Vomiting—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000882	CcSEcCtD
Prazosin—Insomnia—Ramipril—type 2 diabetes mellitus	7.16e-05	0.00088	CcSEcCtD
Prazosin—Headache—Valsartan—type 2 diabetes mellitus	7.15e-05	0.000879	CcSEcCtD
Prazosin—ABCB1—pancreas—type 2 diabetes mellitus	7.13e-05	0.00685	CbGeAlD
Prazosin—Diarrhoea—Metformin—type 2 diabetes mellitus	7.11e-05	0.000874	CcSEcCtD
Prazosin—Rash—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000874	CcSEcCtD
Prazosin—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000874	CcSEcCtD
Prazosin—Dermatitis—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000873	CcSEcCtD
Prazosin—Headache—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000869	CcSEcCtD
Prazosin—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000868	CcSEcCtD
Prazosin—Asthenia—Irbesartan—type 2 diabetes mellitus	7.04e-05	0.000865	CcSEcCtD
Prazosin—Somnolence—Ramipril—type 2 diabetes mellitus	7.04e-05	0.000865	CcSEcCtD
Prazosin—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.99e-05	0.00672	CbGeAlD
Prazosin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000853	CcSEcCtD
Prazosin—Dizziness—Metformin—type 2 diabetes mellitus	6.87e-05	0.000845	CcSEcCtD
Prazosin—Fatigue—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000839	CcSEcCtD
Prazosin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.8e-05	0.000836	CcSEcCtD
Prazosin—Nausea—Valsartan—type 2 diabetes mellitus	6.78e-05	0.000834	CcSEcCtD
Prazosin—Constipation—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000832	CcSEcCtD
Prazosin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000825	CcSEcCtD
Prazosin—Nausea—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000824	CcSEcCtD
Prazosin—Asthenia—Losartan—type 2 diabetes mellitus	6.62e-05	0.000814	CcSEcCtD
Prazosin—Vomiting—Metformin—type 2 diabetes mellitus	6.61e-05	0.000812	CcSEcCtD
Prazosin—Rash—Metformin—type 2 diabetes mellitus	6.55e-05	0.000806	CcSEcCtD
Prazosin—Dermatitis—Metformin—type 2 diabetes mellitus	6.55e-05	0.000805	CcSEcCtD
Prazosin—Pruritus—Losartan—type 2 diabetes mellitus	6.53e-05	0.000803	CcSEcCtD
Prazosin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000802	CcSEcCtD
Prazosin—Headache—Metformin—type 2 diabetes mellitus	6.51e-05	0.000801	CcSEcCtD
Prazosin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000797	CcSEcCtD
Prazosin—ABCB1—adipose tissue—type 2 diabetes mellitus	6.47e-05	0.00622	CbGeAlD
Prazosin—Diarrhoea—Losartan—type 2 diabetes mellitus	6.32e-05	0.000777	CcSEcCtD
Prazosin—Urticaria—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000773	CcSEcCtD
Prazosin—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000769	CcSEcCtD
Prazosin—Vomiting—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000767	CcSEcCtD
Prazosin—Rash—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.00076	CcSEcCtD
Prazosin—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.00076	CcSEcCtD
Prazosin—Nausea—Metformin—type 2 diabetes mellitus	6.17e-05	0.000759	CcSEcCtD
Prazosin—Headache—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000755	CcSEcCtD
Prazosin—Dizziness—Losartan—type 2 diabetes mellitus	6.1e-05	0.00075	CcSEcCtD
Prazosin—Vomiting—Losartan—type 2 diabetes mellitus	5.87e-05	0.000722	CcSEcCtD
Prazosin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000717	CcSEcCtD
Prazosin—Nausea—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000716	CcSEcCtD
Prazosin—Rash—Losartan—type 2 diabetes mellitus	5.82e-05	0.000716	CcSEcCtD
Prazosin—Dermatitis—Losartan—type 2 diabetes mellitus	5.82e-05	0.000715	CcSEcCtD
Prazosin—Headache—Losartan—type 2 diabetes mellitus	5.78e-05	0.000711	CcSEcCtD
Prazosin—Asthenia—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000698	CcSEcCtD
Prazosin—Pruritus—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000688	CcSEcCtD
Prazosin—Nausea—Losartan—type 2 diabetes mellitus	5.48e-05	0.000674	CcSEcCtD
Prazosin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000666	CcSEcCtD
Prazosin—Dizziness—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000644	CcSEcCtD
Prazosin—Vomiting—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000619	CcSEcCtD
Prazosin—Rash—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000614	CcSEcCtD
Prazosin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000613	CcSEcCtD
Prazosin—Headache—Ramipril—type 2 diabetes mellitus	4.96e-05	0.00061	CcSEcCtD
Prazosin—Nausea—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000578	CcSEcCtD
Prazosin—ABCB1—liver—type 2 diabetes mellitus	4.54e-05	0.00436	CbGeAlD
Prazosin—ADRA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.96e-06	3.19e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.96e-06	3.19e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.96e-06	3.18e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.95e-06	3.17e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	1.95e-06	3.17e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.94e-06	3.16e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.94e-06	3.15e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.94e-06	3.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	1.93e-06	3.13e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.92e-06	3.12e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.91e-06	3.11e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.91e-06	3.11e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.91e-06	3.1e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.91e-06	3.1e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.9e-06	3.09e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.9e-06	3.08e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	1.9e-06	3.08e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.9e-06	3.08e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	3.08e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.89e-06	3.07e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	1.89e-06	3.07e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.89e-06	3.06e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.87e-06	3.04e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.87e-06	3.04e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	1.87e-06	3.03e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.86e-06	3.02e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	1.85e-06	3.01e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.85e-06	3e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.83e-06	2.98e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	1.83e-06	2.97e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	2.94e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	2.94e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.81e-06	2.94e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.81e-06	2.93e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.79e-06	2.91e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.79e-06	2.91e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.79e-06	2.91e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	1.78e-06	2.89e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.77e-06	2.87e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.76e-06	2.85e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.75e-06	2.84e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	2.84e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.74e-06	2.83e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.74e-06	2.82e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.74e-06	2.82e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.74e-06	2.82e-05	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.73e-06	2.81e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.73e-06	2.81e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.73e-06	2.81e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.72e-06	2.8e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.72e-06	2.8e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.72e-06	2.79e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.72e-06	2.79e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.71e-06	2.79e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.71e-06	2.78e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.71e-06	2.78e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.71e-06	2.78e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.71e-06	2.77e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.71e-06	2.77e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.7e-06	2.77e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.7e-06	2.77e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.7e-06	2.76e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.7e-06	2.76e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	1.7e-06	2.76e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.69e-06	2.75e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.68e-06	2.73e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.68e-06	2.73e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.67e-06	2.71e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.67e-06	2.71e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.67e-06	2.71e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.66e-06	2.7e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.66e-06	2.7e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	2.69e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.65e-06	2.69e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	1.65e-06	2.67e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-06	2.67e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.64e-06	2.66e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.64e-06	2.66e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	1.64e-06	2.66e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.63e-06	2.65e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.63e-06	2.65e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	1.63e-06	2.64e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.62e-06	2.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.62e-06	2.63e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.62e-06	2.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.61e-06	2.62e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	2.62e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.61e-06	2.62e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.61e-06	2.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	1.61e-06	2.61e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.6e-06	2.61e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	2.6e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.59e-06	2.58e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.59e-06	2.58e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.58e-06	2.57e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.58e-06	2.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.58e-06	2.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.58e-06	2.57e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.58e-06	2.56e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.57e-06	2.56e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	2.55e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.56e-06	2.54e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.56e-06	2.53e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.56e-06	2.53e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.56e-06	2.53e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	2.48e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.53e-06	2.48e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.52e-06	2.47e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.52e-06	2.46e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-06	2.45e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-06	2.45e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.5e-06	2.44e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	2.43e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.49e-06	2.42e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.48e-06	2.41e-05	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.48e-06	2.41e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	2.4e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.47e-06	2.39e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.47e-06	2.38e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.46e-06	2.38e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.46e-06	2.37e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.45e-06	2.36e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-06	2.36e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.43e-06	2.33e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.43e-06	2.33e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.43e-06	2.32e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-06	2.32e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	2.3e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.42e-06	2.3e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.42e-06	2.3e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.41e-06	2.29e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.41e-06	2.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.4e-06	2.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.4e-06	2.27e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.4e-06	2.27e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	2.25e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.38e-06	2.24e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.37e-06	2.23e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	1.35e-06	2.19e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.35e-06	2.19e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.34e-06	2.18e-05	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.34e-06	2.17e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-06	2.17e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-06	2.17e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.33e-06	2.17e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.33e-06	2.16e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	2.15e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.32e-06	2.14e-05	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.31e-06	2.13e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.31e-06	2.13e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-06	2.13e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.31e-06	2.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.31e-06	2.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.3e-06	2.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.3e-06	2.11e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	2.1e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.29e-06	2.1e-05	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	2.1e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.28e-06	2.08e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	2.08e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	2.08e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.07e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-06	2.07e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	2.06e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.25e-06	2.03e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	2.02e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.24e-06	2.01e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.24e-06	2.01e-05	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.23e-06	2e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-06	1.99e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-06	1.99e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.98e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	1.97e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.21e-06	1.97e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.96e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-06	1.95e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-06	1.92e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.9e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	1.87e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.15e-06	1.87e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.85e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.14e-06	1.85e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	1.83e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.82e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	1.82e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.12e-06	1.81e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.81e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-06	1.81e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.81e-05	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-06	1.77e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.76e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-06	1.76e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-06	1.75e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.06e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.03e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	1.68e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.02e-06	1.66e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-06	1.66e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	1.65e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	1.64e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-06	1.64e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-06	1.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.01e-06	1.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.99e-07	1.62e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.96e-07	1.62e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.91e-07	1.61e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.79e-07	1.59e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.79e-07	1.59e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.77e-07	1.59e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.5e-07	1.54e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.49e-07	1.54e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.42e-07	1.53e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.4e-07	1.53e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.3e-07	1.51e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.28e-07	1.51e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.21e-07	1.5e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.18e-07	1.49e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	8.95e-07	1.45e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.76e-07	1.42e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.61e-07	1.4e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.53e-07	1.39e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.43e-07	1.37e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	8.32e-07	1.35e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.26e-07	1.34e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	8.24e-07	1.34e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.94e-07	1.29e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.83e-07	1.27e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.77e-07	1.26e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.68e-07	1.25e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.68e-07	1.25e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.51e-07	1.22e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.17e-07	1.17e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.15e-07	1.16e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.92e-07	1.12e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.59e-07	1.07e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	6.51e-07	1.06e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.35e-07	1.03e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.9e-07	9.58e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.86e-07	9.51e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	5.63e-07	9.15e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.44e-07	8.84e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.5e-07	7.31e-06	CbGpPWpGaD
